At Novum, integrity is everything.
You expect it from your research partners. We demand it in the studies we design, conduct and manage and in how we work with you.
Trust 40-plus years of industry experience. Novum is a full-service CRO with numerous FDA approvals in ANDA and NDA submissions. We conduct more than 250 studies a year across multiple therapeutic areas and have developed long-standing relationships with a wide range of global sponsors who rely on our Early Phase Research and Clinical Trial Management expertise. Read More »
Novum provides a full spectrum of services in managing multicenter Clinical Endpoint Studies and in conducting Early Phase Studies in our Novum facilities, from protocol design to final report. We offer reliable, turnkey solutions for your drug development program and ensure that every service we perform is designed to provide timely output of the high-quality data your study demands.
Novum’s Scientific Leadership Presented Transdermal Poster at AAPS 2017 on November 13th at 1 pm.
Reflecting Novum’s industry leadership in transdermal clinical research, senior Scientific Affairs members Martin Kozicki, Pina D’Angelo, Niraj Shethji, and CSO Keith Gallicano presented A Comparison of Statistical Methods for Assessing Adhesion with Transdermal Delivery Systems at the AAPS Annual Meeting in San Diego, CA. The poster compared the adhesion results from the historical NI approach with those from the new statistical NI approach, delineated in the FDA draft guidance issued June 2016.
Keith D. Gallicano Was Invited to be a Panelist at The 2017 Association for Accessible Medicines (AAM) Fall Technical Conference
Keith D. Gallicano was invited to be a Panelist at The 2017 Association for Accessible Medicines (AAM) Fall Technical Conference on November 6-8, 2017 at the Bethesda North Marriott Hotel and Conference Center in North Bethesda, Maryland.
NOVUM EXPANDS, UPGRADES LAS VEGAS CLINICAL FACILITY
We are pleased to announce that Novum has completed a multi-year expansion and upgrade of our Las Vegas, Nevada Clinical Pharmacology Unit. Novum has operated in Las Vegas since 2004, conducting a wide range of ANDA/NDA studies across virtually all dosage forms. With a modernized facility, we can continue to create a positive and safe environment for our study participants, and ensure successful recruitment and outcomes for our sponsors varied studies with a more efficient workflow in place. Read More »